Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 1320Neoplasms 1100Carcinoma, Non-Small-Cell Lung 911Prostatic Neoplasms 741Colorectal Neoplasms 648Lung Neoplasms 611Neoplasm Metastasis 469Multiple Myeloma 444Leukemia, Myeloid, Acute 428Pancreatic Neoplasms 388Ovarian Neoplasms 387Melanoma 342Carcinoma, Hepatocellular 308Recurrence 289Brain Neoplasms 286Squamous Cell Carcinoma of Head and Neck 284Glioblastoma 259Head and Neck Neoplasms 253Stomach Neoplasms 251Precursor Cell Lymphoblastic Leukemia-Lymphoma 240Carcinoma, Renal Cell 237Triple Negative Breast Neoplasms 233Lymphoma 232Endometrial Neoplasms 221Hematologic Neoplasms 214Uterine Cervical Neoplasms 212Urinary Bladder Neoplasms 210Lymphoma, Non-Hodgkin 205Glioma 202Sarcoma 201

Interventions

itacitinib 1INCB039110 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
B-cell Malignancies × 90 days × Clear all
NCT01905813 2026-05-11

Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies

Incyte Corporation

Phase 1 Completed
121 enrolled
Lymphoid

B-cell Malignancies

NCT07515313 2026-04-07

Expression of CD274 (PD-L1) and CD276 in B-cell Malignancies: A Study by Flowcytometry

Assiut University

Not yet recruiting
159 enrolled
Lymphoid

B-cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡